+86 27 8798 8585
| |

About Us

You are at the location of:Home - About Us - Management

Management Team

Our members of management team have 20+ years of work experience in large and medium-sized bio-pharmaceuticals and organizations, covering various fields such as R&D, manufacturing, quality management, marketing, procurement, logistics etc. As professional, dynamic, self-motivated and dedicated team-players, the members have successfully passed multiple national and international GMP audits.

  • Wu Ke

    Chief Executive Officer

    Dr. Wu Ke is the Chair and CEO of BravoVax, also President and founder of BravoBio. He has more than 25 years of experiences in biopharm industry and had successfully developed 7 products being approved by CFDA and marketed in China.
  • Pele Chong

    Chief Operating Officer

    Dr. Chong is a results-oriented senior-level executive with >30 years of experience in the vaccine biotechnology/biopharmaceutical industry. Before joining BravoVax, he has been served as Research Director, Human Vaccine Research and Development.
  • Shi Jin

    Vice President

    Mr. Shi worked in Quality Assurance Department of Wuhan Institute of Biological Products from 1984 to 2004, responsible for the production, quality control and assurance of biologic products.
  • Liu Haozhi

    Vice President

    Mr. Liu has been working in biological products industry for more than 20 years. Prior to joining BravoVax, he worked in Shanghai Sunway Biotech Co., Ltd, responsible for the development of new products and production.
  • Du Linsen

    Vice President

    Dr. Du received her Ph.D from National University of Singapore, and her bachelor degree from Zhejiang University. Prior to joining BravoVax, she was holding the position as the lead scientist of Covance (Asia) Pte Ltd.,
  • Kelly McKee

    Chief Medical Officer

    Dr. Kelly graduated from Resident in Preventive Medicine, Walter Reed Army Institute of Research, Washington, DC.Medical/scientific leader of vaccine and public health initiatives in Quintiles’ Infectious Diseases and Vaccines Center of Excellence.
  • Charles Sia

    Senior Scientific Advisor

    Dr. Sia has a Ph.D in Microbiology of Australian National University.He has over 50 years of work experience in biological products industry. Prior to joining BravoVax, he was a Research Scientist/Project Leader at Sanofi Pasteur.
  • Kang Guangming

    HR & Admin Director

    Mr. Kang has been engaged in biological products industry for more than 30 years. In his early years, he worked at Wuhan Institute of Biological Products as office director, responsible for research and production of biological products.
  • Li Jin

    Business Development Director

    Dr. Li received his Ph.D from Peking University Health Science Center, and his bachelor degree from Capital Normal University. He has over 30 years of experience in vaccine R&D field.
  • Zhang Xiaoshu

    Business Development Director

    Ms. Xiaoshu Zhang is the Business Development Director of BravoVax Co., Ltd, specializing in licensing in/out deals. She graduated from State University of Albany,New York in 2005.
  • Michel Klein

    SAB Chairman

    Dr.Klein held the positions of Vice President Research of Pasteur Mérieux Connaught and of Vice President, Science and Technology, of the Aventis-Pasteur Group, now Sanofi Pasteur.